𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Androgen receptor - an update of mechanisms of action in prostate cancer

✍ Scribed by Culig, Z. ;Hobisch, A. ;Bartsch, G. ;Klocker, H.


Publisher
Springer
Year
2000
Tongue
English
Weight
120 KB
Volume
28
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Androgen receptor action in hormone-depe
✍ Irina U. Agoulnik; Nancy L. Weigel πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 177 KB

## Abstract The importance of androgens and androgen receptors (AR) in primary prostate cancer is well established. Metastatic disease is usually treated with some form of androgen ablation, which is effective for a limited amount of time. The role of AR in prostate cancers that recur despite andro

Molecular regulation of androgen action
✍ Scott M. Dehm; Donald J. Tindall πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 178 KB

## Abstract Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the and

Pleiotropic functional properties of and
✍ Jean-Pierre Bergerat; Jocelyn CΓ©raline πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 279 KB

The androgen receptor (AR) signaling pathway plays an important role during the development of the normal prostate gland, but also during the progression of prostate cancer on androgen ablation therapy. Mutations in the AR gene emerge to keep active the AR signaling pathway and to support prostate c

The androgen receptor can signal through
✍ Liang Schweizer; Cheryl A Rizzo; Thomas E Spires; J Suso Platero; Qiuyan Wu; Tai πŸ“‚ Article πŸ“… 2008 πŸ› BioMed Central 🌐 English βš– 816 KB

## Background A crucial event in Prostate Cancer progression is the conversion from a hormone-sensitive to a hormone-refractory disease state. Correlating with this transition, androgen receptor (AR) amplification and mutations are often observed in patients failing hormonal ablation therapies. Ξ²-C

Androgen receptor status of lymph node m
✍ Hobisch, Alfred; Culig, Zoran; Radmayr, Christian; Bartsch, Georg; Klocker, Helm πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 594 KB

To date androgen receptor (AR) expression and structure in human prostatic cancer have been studied in primary tumor specimens and in cell lines. Investigation of alterations in the androgen-signalling transduction cascade in prostatic carcinoma metastases is important to improve our understanding o